About 64,498 results

ALLMedicine™ Headache Center

Research & Reviews  14,589 results

COVID-19-associated encephalitis or Creutzfeldt-Jakob disease: a case report.
Neurodegenerative Disease Management; Tayyebi G, Malakouti SK et. al.

Dec 3rd, 2021 - Background: Accurate diagnosis and management of patients with rapidly progressive dementia may be challenging during the COVID-19 pandemic, which has negatively influenced the diagnostic performances, medical resource allocation and routine care ...

Risk factors in central retinal vein occlusion: A multi-center case-control study condu...
European Journal of Ophthalmology; Edoardo TB, Fernanda P et. al.

Dec 3rd, 2021 - To explore the risk factors for central retinal vein occlusion (CRVO) by comparing a large sample of patients with healthy controls. Multi-center case-control study. The study group includes patients affected by central retinal vein occlusion, con...

Paralysis from an ear infection: a severe case of otitis externa leading to acute compl...
BMJ Case Reports; Collins R, Lafford G et. al.

Dec 3rd, 2021 - We report a case of a generally fit and well 54-year-old man who presented with a 2-day history of worsening left-sided otorrhea, headache, neck stiffness, vomiting and fever on the background of a 7-week history of otitis externa (OE). His condit...

Ginger for Migraine.
The Journal of Clinical Psychiatry; Andrade C

Dec 2nd, 2021 - Many preclinical and clinical studies have examined the potential benefits of ginger extracts for a range of medical disorders. Ginger has been found to reduce both pain and nausea and has therefore also been studied in the context of migraine hea...

Sumatriptan as Treatment for Post-traumatic Headache

Dec 1st, 2021 - I. Specific Aims of Study: The ultimate aim of this Phase II open-label study is to test the research methods and approach necessary to successfully carry out a Phase III study for the treatment of post-traumatic headache (PTH). During this study,...

see more →

Guidelines  25 results

Editorial. Valuing headache's solution.
The Journal of Headache and Pain; Steiner TJ, Tinelli M

Jun 12th, 2021 - Editorial. Valuing headache's solution.|2021|Steiner TJ,Tinelli M,|diagnosis,prevention & control,diagnosis,prevention & control,diagnosis,prevention & control,diagnosis,prevention & control,diagnosis,prevention & control,diagnosis,prevention & co...

Glucocorticoid use in patients with adrenal insufficiency following administration of t...
Pituitary Katznelson L, Gadelha M

Feb 11th, 2021 - Side effects of the coronavirus disease 2019 (COVID-19) vaccines include pain at the injection site, fatigue, headache, myalgias, arthralgias, chills, and fever, all of which can be early indicators of an increased need for glucocorticoid replacem...

Guidelines of the International Headache Society for controlled trials of preventive tr...
Cephalalgia : an International Journal of Headache; Diener HC, Tassorelli C et. al.

Jul 30th, 2020 - Clinical trials are a key component of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for Contro...

ACR Appropriateness Criteria® Cerebrovascular Disease-Child.
Journal of the American College of Radiology : JACR; , Robertson RL et. al.

May 7th, 2020 - Stroke is an uncommon but an important and under-recognized cause of morbidity and mortality in children. Strokes may be due to either brain ischemia or intracranial hemorrhage. Common symptoms of pediatric acute stroke include headache, vomiting,...

Transcranial Magnetic Stimulation for Pain, Headache, and Comorbid Depression: INS-NANS...
Neuromodulation : Journal of the International Neuromodul... Leung A, Shirvalkar P et. al.

Mar 27th, 2020 - While transcranial magnetic stimulation (TMS) has been studied for the treatment of psychiatric disorders, emerging evidence supports its use for pain and headache by stimulating either motor cortex (M1) or dorsolateral prefrontal cortex (DLPFC). ...

see more →

Drugs  6,774 results see all →

Clinicaltrials.gov  615 results

Sumatriptan as Treatment for Post-traumatic Headache

Dec 1st, 2021 - I. Specific Aims of Study: The ultimate aim of this Phase II open-label study is to test the research methods and approach necessary to successfully carry out a Phase III study for the treatment of post-traumatic headache (PTH). During this study,...

The Effect of Ganglion Sphenopalatine Block Versus Placebo on Persistent Headache Following COVID-19 Infection

Nov 29th, 2021 - Adult patients with persistent headache following COVID-19 infection will be enrolled in the study. The patients will be randomised into three groups; bilateral SPG-block withto receive local anesthetic (lidocaine + ropivacaine), bilateral SPG-blo...

Clinical Characteristics of Acutely Hospitalized Adults With Community-acquired- Pneumonia

Nov 29th, 2021 - Currently, pneumonia diagnosis is primarily based on clinical symptoms such as cough, shortness of breath, chest pain, fever and sputum production, combined with X-ray of the lungs, relevant blood tests and microbiological analysis of sputum sampl...

Spenopalatine Ganglion Block for Treatment of Post-dural Puncture Headaches

Nov 29th, 2021 - Postdural puncture headache (PDPH) is a severe, debilitating complication of dural puncture that can arise from insertion of an epidural or spinal needle for labour analgesia. Presently, the conservative treatment options for PDPH have limited eff...

Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Migraine

Nov 24th, 2021 - This is a clinical trial to assess the efficacy of botox treatment of the sphenopalatine ganglion as an add-on treatment in drug resistant migraine. An injection targeting the ganglion is made possible by an image-guided device developed specifica...

see more →

News  3,632 results

New Type of Hepatitis B Vaccine OK'd

Dec 2nd, 2021 - The FDA approved the first three-antigen hepatitis B vaccine (PreHevbrio) to prevent infection from all known subtypes in adults, VBI Vaccines announced on Wednesday. Approval for the recombinant vaccine -- which contains the S, pre-S1, and pre-S2...

Microbleeds, age contribute to ARIA risk with aducanumab
Jennie Smith

Nov 30th, 2021 - Though primary efficacy results have yet to be published, new safety findings from two large, randomized trials of aducanumab offer details on which patients are more likely to experience complications associated with the controversial Alzheimer’s.

Opioids for headache?
Jim Kling

Nov 29th, 2021 - The use of opiates in the treatment of headache has a controversial history, and it remains a matter of debate today. Some believe that the medications, though risky, can be a useful tool in the neurologist’s treatment arsenal, while others argue.

Headache is a common post–COVID-19 complaint
Jim Kling

Nov 24th, 2021 - Post–COVID-19 headache is a common and sometimes persistent problem. It may take the form of new-onset headache, or exacerbations of preexisting headache conditions such as migraine.

Brain Inflammation Seen in Four of 10 Alzheimer's Aducanumab Patients

Nov 22nd, 2021 - Brain inflammation known as amyloid-related imaging abnormalities (ARIA) occurred in about 40% of people with early Alzheimer's disease in the two phase III studies of aducanumab (Aduhelm), a secondary analysis of trial data showed. In an integrat...

see more →

Patient Education  164 results see all →